Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Breath Analysis Distinguishes Between Malignant and Benign Pulmonary Nodules

By LabMedica International staff writers
Posted on 02 Oct 2012
The volatile organic compounds in exhaled breath were examined by two techniques, gas chromatography with mass spectrometry, and chemical nanoarrays.

Exhaled breath was collected from 74 patients who were under investigation for pulmonary nodules and attended a referral clinic in Colorado between March 2009 and May 2010. More...
Scientists from Israel and Colorado analyzed the exhaled breath from each patient for volatile organic compounds. The patients also underwent a bronchoscopy, wedge resection, and/or lobectomy, whichever was required for final diagnosis. Nodules that either regressed or remained stable over a 24-month period were considered benign.


Profiles of volatile organic compounds were determined by gas chromatography/mass spectrometry (GC-MS) combined with solid-phase microextraction and by a chemical nanoarray. Both techniques accurately identified that 53 pulmonary nodules were malignant and 19 were benign.


The chemical nanoarrays also discriminated between adenocarcinoma and squamous cell carcinoma and between early versus advanced disease. The nanoarrays were developed by Prof. Hossam Haick and his colleagues at the Technion-Israel Institute of Technology (Haifa, Israel).


The pilot study, in order to be validated, needs to be repeated using a larger cohort of subjects. The testing could serve as a secondary screener for patients who were found to have pulmonary nodules after CT screening. Low-dose CT screening has reduced the mortality rate by 20% but many people still undergo invasive procedures only to learn that their pulmonary nodules are not cancerous.


The pilot study was published in the October 2012 issue of the International Association for the Study of Lung Cancer’s (IASLC) Journal of Thoracic Oncology.


The authors commented, “The reported breath test in this study could have significant impact on reducing unnecessary investigation and reducing the risk of procedure-related morbidity and costs. In addition, it could facilitate faster therapeutic intervention, replacing time-consuming clinical follow-up that would eventually lead to the same intervention.”

Related Links:
Technion-Israel Institute of Technology



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.